Abstract

Human papillomavirus(HPV) infection is one of the most common sexually transmitted diseases. High risk HPV genotypes play an important role in cervical cancas well as other anogenital cancers. Prophylactic HPV vaccines which against HPV6,11,16, 18 have been developed to reduce HPV infection and HPV-related cervical and other anogenital cancers. Up to now, the prophylactic vaccines have been used worldwide. In this article, the research and application advances of the prophylactic HPV vaccines are reviewed. Key words: Papillomavirus vaccines; Prevention; Applications

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call